Ignite Creation Date:
2024-05-06 @ 3:00 AM
Last Modification Date:
2024-10-26 @ 11:26 AM
Study NCT ID:
NCT02173249
Status:
COMPLETED
Last Update Posted:
2017-09-14
First Post:
2014-06-13
Brief Title:
A Single-Center Open-Label Study of the Plasma Pharmacokinetics and Safety of AC-170 024
Sponsor:
Aciex Therapeutics Inc
Organization:
Aciex Therapeutics Inc
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2017-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the Plasma Pharmacokinetics and Safety of AC 170 024 in Healthy Adult Subjects when used twice daily for one week
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None